Metabolism

Metabolic

6 drugs in development·6 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
fludeoxyglucose f18	Cardinal Health Inc. (CAH)
fludeoxyglucose f18	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
metabolic health	Thorne Healthtech, Inc. (THRN)

Phase 3(2)

Drug	Company
mipomersen	TG THERAPEUTICS, INC. (TGTX)
venglustat	Sanofi (SNY)

Phase 2(1)

Drug	Company
cardiopet	FLUOROPHARMA MEDICAL, INC. (FPMI)

BioSniper tracks 6 drugs in development for Metabolism across 6 companies.

There are 2 clinical trials targeting Metabolism tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.